MedTrace Logo

Veteran's Interdisciplinary Care for Traumatic Brain Injury and Co-Occurring Disorders Rehabilitation Trial

NCT07463027 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 416

Last updated 2026-04-02

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the Avalon Action Alliance Interdisciplinary Outpatient Rehabilitation Program (IORP) can reduce long-lasting symptoms of traumatic brain injury (TBI) and co-occurring disorders in veterans and first responders. The main questions it aims to answer are:

* Does a 3-week IORP reduce symptoms of long-lasting TBI and co-occurring disorders in military veterans and first responders?
* Does the 3-week IORP improve life quality and function in military veterans and first responders?

Researchers will compare the Control group to the Invention group to see if a 3-week of IORP reduced symptoms of TBI and co-occurring disorders in military veterans and first responders.

Participants will complete the following activities. The items with an asterisk(\*) are not required or available at all sites.

* Answer online survey questions about their TBI symptoms, life satisfaction, and life activities
* Complete two blood draws\*
* Complete two magnetic resonance imaging (MRI) brain scans\*

Conditions

  • Traumatic Brain Injury and Co-occurring Disorders

Interventions

BEHAVIORAL

3-week interdisciplinary outpatient rehab program (IORP)

Interdisciplinary outpatient rehabilitation program (IORP) for military veterans and first responders experiencing chronic effects of traumatic brain injury (TBI) and co-occurring disorders (e.g., posttraumatic stress disorder, depression, substance use).

Sponsors & Collaborators

  • University of California, San Diego

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • University of Florida

    collaborator OTHER

  • Moss Rehabilitation Research Institute

    collaborator OTHER

  • University of Colorado Denver - Anschutz Medical Campus (UCD-AMC)

    collaborator UNKNOWN

  • Medical College of Wisconsin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-26
Primary Completion
2029-02-28
Completion
2029-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07463027 on ClinicalTrials.gov